We Are Advocates

Our unparalleled team of doctors, clinicians, lawyers, and business leaders have distinctive and extensive real-world experience in alternative medicine.

We believe in the life-changing benefits of Ketamine-Assisted Therapy. We advocate through our innovation, education, implementation, and philanthropy.

  • Warren Gumpel

    Founder and CEO

    Warren Gumpel is a pioneer in mental health, having made numerous contributions over the last 10 years as an advocate, entrepreneur, film and television producer, operator and consultant. He has worked with various providers across the U.S. to help them implement best practices in ketamine and improve their care outcomes. Warren co-founded KetaMD, a telemedicine ketamine treatment provider with the goal of expanding access to ketamine through at-home treatment. He also cofounded the non-profit organization, The Ketamine Fund, which aims to reduce rates of suicide by making ketamine accessible to veterans, first responders, and others who need it. Additionally, Warren has been active in educating the public about psychedelic assisted treatment through the media. As Executive Producer of the documentary film, Lamar Odom: Reborn, he believes Odom’s story will increase awareness about breakthrough treatment for depression, PTSD, and addiction

  • Sandra Statz

    President & CMO

    Sandra Statz is a marketing and business development leader with more than 15 years of experience working with Fortune 500 companies, including LVMH Louis Vuitton Moet Hennessy and The Estee Lauder Companies Inc. She developed A.P. CHEM®, an award-winning consumer brand with a mission to advocate for mental and physical health disorders, inspired by her diagnosis with an autoimmune disease. Her physical and mental health journey led her to ketamine treatment. She is now an active advocate for psychedelic-assisted therapy. In addition to her role at 8CA, she serves as a board member of The Ketamine Fund, a member of the marketing committee for the Women in Psychedelics Network, and as a confidant for individuals exploring treatment options.

Board of Advisors

Dr. Joshua Pal MD, PHD.

Board-Certified Anesthesiologist, Board-Certified Pain Management Specialist Learn more here.

Daniel Kang, MD

Board-Certified Anesthesiologist, Former Chief Medical Officer, KetaMD Learn more here

David Feifel, MD, PhD

Founder of Kadima Neuropsychiatry Institute, Board-Certified Psychiatrist, Specialization in Neuropsychiatry and Behavioral Neurology. Learn more here.

Scott Bienenfeld, MD, FAPA, FASAM

Board-Certified Psychiatrist, Specialization in Forensic Psychiatry, Preventive & Addiction Medicine Learn more here.

OUR PURPOSE

To empower licensed medical facilities to implement and optimize innovative, evidence-based mental health treatments while successfully scaling their business.

OUR MISSION

To improve patient outcomes by expanding access to advanced treatments.

8CA EXPERTISE

Our team is comprised of leaders of industry, with deep expertise in ketamine, SPRAVATO®, TMS, as well as other interventional psychiatric and psychedelic-assisted treatments.

8CA APPROACH

Our focus is first and foremost on access to safe, effective, evidence-based treatment according to the highest standard of care. Our tailored and turnkey solutions are rooted in clinical compassion as well as operational efficiency and financial return.

ADVOCACY

We are advocates. Every member of our team has personally experienced the life-changing benefits of psychedelic-assisted treatment or interventional psychiatric care. We pay it forward through innovation, education, advocacy, and philanthropy.